We previously characterized the genome-wide binding of KMT2A-AFF1 (Kerry et al. 2017) in SEM cells, a patient-derived B-ALL KMT2A-AFF1 cell line (Greil et al. 1994). This evidence concerns the gene AFF1 and precursor B-cell acute lymphoblastic leukemia.